Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis

被引：0
|
作者：
Mingfeng He [1 ]
Xue Wu [1 ]
Li Li [2 ]
Guangming Yi [1 ]
Yitian Wang [4 ]
Hengqiu He [1 ]
Ying Ye [1 ]
Ruiqin Zhou [2 ]
Zaicheng Xu [3 ]
Zhenzhou Yang [1 ]
机构：
[1] The Second Affiliated Hospital of Chongqing Medical University,Department of Oncology
[2] The Second Affiliated Hospital of Chongqing Medical University,Department of Cardiothoracic Surgery
[3] The First Affiliated Hospital of Chongqing Medical University,Department of Cardiothoracic Surgery
[4] The Third Hospital of Mianyang (Sichuan Mental Health Center),Department of Oncology
来源：
Radiation Oncology | / 20卷 / 1期
关键词：
Non-small-cell lung cancer; Brain metastases; EGFR-TKI; Intracranial radiotherapy; Overall survival;
D O I：
10.1186/s13014-024-02578-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
  • [42] Comparing the effectiveness of different EGFR-TKIs in patients with EGFR mutant non-small-cell lung cancer: A retrospective cohort study in Taiwan
    Hsieh, Yao-Yu
    Fang, Wei-Tse
    Lo, Yu-Wen
    Chen, Yi-Han
    Chien, Li-Nien
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (04) : 1107 - 1116
  • [43] EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer
    Sheng, Zhixin
    Zhang, Yanxia
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 7
  • [44] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [45] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yinan Yu
    Jianguo Zhao
    Jiaona Xu
    Rui Bai
    Zewei Gu
    Xialin Chen
    Jianfang Wang
    Xueying Jin
    Gaoyang Gu
    Current Treatment Options in Oncology, 2023, 24 : 1935 - 1947
  • [46] A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer
    Cheng, Hua
    Li, Xiao-Jian
    Wang, Xiao-Jin
    Chen, Zuo-Wen
    Wang, Rui-Qi
    Zhong, Hong-Cheng
    Wu, Tian-Chi
    Cao, Qing-Dong
    LUNG CANCER, 2019, 137 : 7 - 13
  • [47] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yu, Yinan
    Zhao, Jianguo
    Xu, Jiaona
    Bai, Rui
    Gu, Zewei
    Chen, Xialin
    Wang, Jianfang
    Jin, Xueying
    Gu, Gaoyang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1889 - 1916
  • [48] EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer
    Zhixin Sheng
    Yanxia Zhang
    Medical Oncology, 2015, 32
  • [49] The role of adjuvant EGFR-TKIs for completely resected EGFR-mutant non-small cell lung cancer in an era of chemotherapy: An updated systematic review and metaanalysis.
    Qarqash, Aref Ayman
    Araiqat, Bashar
    Awad, Baha
    Aloqaily, Ammar
    Mostafa, Ayah Amjad Bani
    Husenat, Maram
    Atallah, Micheal
    Al-Horani, Sami
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] COMPARISON OF EGFR-TKIS AND PEMETREXED FOR KOREAN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lee, J. H.
    Ryu, Y. J.
    Chun, E. M.
    Chang, J. H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S90 - S90
12345